BIENAIME JEAN JACQUES made five open market purchases of Immunome Inc. ($IMNM) shares worth $209 thousand over the past year, with the latest on March 11, 2026. These rank 1,497th among insiders for purchase value. He also bought Keros Therapeutics ($KROS) shares once for $22 thousand on March 9, 2026, ranking 3,729th. Among 4,983 insiders averaging $1.5 million per buyer and 3.3 transactions, he had no open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 11, 2026 | Immunome Inc. | $IMNM | BIENAIME JEAN JACQUES | Not found | P | Common Stock | 1000 | $21.55 | 38,415.0000 | 91,710,277 | 2.67% | 0.00% |
| March 10, 2026 | Immunome Inc. | $IMNM | BIENAIME JEAN JACQUES | Not found | P | Common Stock | 1000 | $22.12 | 37,415.0000 | 91,710,277 | 2.75% | 0.00% |
| March 9, 2026 | Keros Therapeutics, Inc. | $KROS | BIENAIME JEAN JACQUES | Not found | P | Common Stock | 2000 | $11.21 | 7,450.0000 | 41,202,371 | 36.70% | 0.00% |
| June 10, 2025 | INCYTE CORP | $INCY | BIENAIME JEAN JACQUES | Director | A | Common Stock | 2518 | $0.00 | 20,841.0000 | 210,530,000 | 13.74% | 0.00% |
| June 10, 2025 | Immunome Inc. | $IMNM | BIENAIME JEAN JACQUES | Not found | A | Director Stock Option (right to buy) | 18864 | $0.00 | 18,864.0000 | 0 | 9999.99% | 0.00% |
| June 10, 2025 | INCYTE CORP | $INCY | BIENAIME JEAN JACQUES | Director | A | Non Qualfied Stock Option (right to buy) | 9216 | $0.00 | 9,216.0000 | 210,530,000 | 9999.99% | 0.00% |
| June 4, 2025 | Keros Therapeutics, Inc. | $KROS | BIENAIME JEAN JACQUES | Not found | A | Common Stock | 5250 | $0.00 | 5,450.0000 | 37,437,652 | 2625.00% | 0.01% |
| June 4, 2025 | Keros Therapeutics, Inc. | $KROS | BIENAIME JEAN JACQUES | Not found | A | Stock Option (right to buy) | 10500 | $0.00 | 10,500.0000 | 37,437,652 | 9999.99% | 0.03% |
| June 3, 2025 | Immunome Inc. | $IMNM | BIENAIME JEAN JACQUES | Not found | P | Common Stock | 5000 | $9.38 | 36,415.0000 | 0 | 15.92% | 0.00% |
| March 25, 2025 | Immunome Inc. | $IMNM | BIENAIME JEAN JACQUES | Not found | P | Common Stock | 7800 | $7.78 | 31,415.0000 | 0 | 33.03% | 0.00% |
| March 24, 2025 | Immunome Inc. | $IMNM | BIENAIME JEAN JACQUES | Not found | P | Common Stock | 7000 | $8.21 | 23,615.0000 | 0 | 42.13% | 0.00% |
| Aug. 16, 2024 | Immunome Inc. | $IMNM | BIENAIME JEAN JACQUES | Not found | P | Common Stock | 7000 | $13.94 | 16,615.0000 | 0 | 72.80% | 0.00% |
| June 13, 2024 | Immunome Inc. | $IMNM | BIENAIME JEAN JACQUES | Not found | A | Stock option (right to buy) | 11333 | $0.00 | 11,333.0000 | 0 | 9999.99% | 0.00% |
| June 12, 2024 | INCYTE CORP | $INCY | BIENAIME JEAN JACQUES | Director | A | Non Qualfied Stock Option (right to buy) | 12517 | $0.00 | 12,517.0000 | 225,928,000 | 9999.99% | 0.01% |
| June 12, 2024 | INCYTE CORP | $INCY | BIENAIME JEAN JACQUES | Director | A | Common Stock | 2830 | $0.00 | 18,323.0000 | 225,928,000 | 18.27% | 0.00% |
| June 3, 2024 | Keros Therapeutics, Inc. | $KROS | BIENAIME JEAN JACQUES | Not found | A | Stock Option (right to buy) | 17600 | $0.00 | 17,600.0000 | 29,447,119 | 9999.99% | 0.06% |
| May 21, 2024 | Immunome Inc. | $IMNM | BIENAIME JEAN JACQUES | Not found | P | Common Stock | 2000 | $13.57 | 9,615.0000 | 0 | 26.26% | 0.00% |
| May 20, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Director | F | Common Stock | 1202 | $77.05 | 721,325.0000 | 191,595,000 | 0.17% | 0.00% |
| May 9, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Director | M | Common Stock | 20000 | $63.10 | 742,527.0000 | 191,595,000 | 2.77% | 0.01% |
| May 9, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Director | S | Common Stock | 20000 | $81.62 | 722,527.0000 | 191,595,000 | 2.69% | 0.01% |
| May 10, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Director | M | Common Stock | 20000 | $63.10 | 742,527.0000 | 191,595,000 | 2.77% | 0.01% |
| May 10, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Director | S | Common Stock | 20000 | $81.14 | 722,527.0000 | 191,595,000 | 2.69% | 0.01% |
| May 9, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Director | M | Stock Option (Right to Buy Common Stock) | 20000 | $0.00 | 71,000.0000 | 191,595,000 | 21.98% | 0.01% |
| May 10, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Director | M | Stock Option (Right to Buy Common Stock) | 20000 | $0.00 | 51,000.0000 | 191,595,000 | 28.17% | 0.01% |
| April 11, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Director | M | Common Stock | 20000 | $63.10 | 742,527.0000 | 191,595,000 | 2.77% | 0.01% |
| April 11, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Director | S | Common Stock | 20000 | $90.99 | 722,527.0000 | 191,595,000 | 2.69% | 0.01% |
| April 12, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Director | M | Common Stock | 20000 | $63.10 | 742,527.0000 | 191,595,000 | 2.77% | 0.01% |
| April 12, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Director | S | Common Stock | 20000 | $91.26 | 722,527.0000 | 191,595,000 | 2.69% | 0.01% |
| April 11, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Director | M | Stock Option (Right to Buy Common Stock) | 20000 | $0.00 | 111,000.0000 | 191,595,000 | 15.27% | 0.01% |
| April 12, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Director | M | Stock Option (Right to Buy Common Stock) | 20000 | $0.00 | 91,000.0000 | 191,595,000 | 18.02% | 0.01% |
| March 15, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Director | F | Common Stock | 85209 | $83.87 | 722,527.0000 | 191,595,000 | 10.55% | 0.04% |
| March 6, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Director | S | Common Stock | 1000 | $86.71 | 807,736.0000 | 191,595,000 | 0.12% | 0.00% |
| March 5, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Director | S | Common Stock | 1000 | $85.51 | 808,736.0000 | 191,595,000 | 0.12% | 0.00% |
| Feb. 27, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Director | S | Common Stock | 1000 | $90.35 | 809,736.0000 | 191,595,000 | 0.12% | 0.00% |
| Feb. 27, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Director | A | Common Stock | 82700 | $0.00 | 749,835.0000 | 191,595,000 | 12.40% | 0.04% |
| Feb. 27, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Director | A | Common Stock | 24926 | $0.00 | 810,736.0000 | 191,595,000 | 3.17% | 0.01% |
| Feb. 27, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Director | A | Common Stock | 35975 | $0.00 | 785,810.0000 | 191,595,000 | 4.80% | 0.02% |
| Feb. 6, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Director | G | Common Stock | 1000 | $0.00 | 671,695.0000 | 188,963,000 | 0.15% | 0.00% |
| Jan. 18, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Director | L | Common Stock | 40 | $92.60 | 667,135.0000 | 191,595,000 | 0.01% | 0.00% |
| Feb. 8, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Director | M | Common Stock | 15000 | $63.10 | 682,135.0000 | 191,595,000 | 2.25% | 0.01% |
| Feb. 8, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Director | S | Common Stock | 15000 | $89.77 | 667,135.0000 | 191,595,000 | 2.20% | 0.01% |
| Feb. 9, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Director | M | Common Stock | 15000 | $63.10 | 682,135.0000 | 191,595,000 | 2.25% | 0.01% |
| Feb. 9, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Director | S | Common Stock | 15000 | $88.28 | 667,135.0000 | 191,595,000 | 2.20% | 0.01% |
| Feb. 8, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Director | M | Stock Option (Right to Buy Common Stock) | 15000 | $0.00 | 146,000.0000 | 191,595,000 | 9.32% | 0.01% |
| Feb. 9, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Director | M | Stock Option (Right to Buy Common Stock) | 15000 | $0.00 | 131,000.0000 | 191,595,000 | 10.27% | 0.01% |
| Feb. 7, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Director | G | Common Stock | 4400 | $0.00 | 667,295.0000 | 188,963,000 | 0.66% | 0.00% |
| Feb. 9, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Director | G | Common Stock | 200 | $0.00 | 667,095.0000 | 188,963,000 | 0.03% | 0.00% |
| Jan. 9, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Director | M | Common Stock | 10000 | $63.10 | 682,695.0000 | 191,595,000 | 1.49% | 0.01% |
| Jan. 9, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Director | S | Common Stock | 10000 | $98.19 | 672,695.0000 | 191,595,000 | 1.46% | 0.01% |
| Jan. 10, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Director | S | Common Stock | 10000 | $96.38 | 672,695.0000 | 191,595,000 | 1.46% | 0.01% |
| Jan. 10, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Director | M | Common Stock | 10000 | $63.10 | 682,695.0000 | 191,595,000 | 1.49% | 0.01% |
| Jan. 10, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Director | M | Stock Option (Right to Buy Common Stock) | 10000 | $0.00 | 161,000.0000 | 191,595,000 | 5.85% | 0.01% |
| Jan. 9, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Director | M | Stock Option (Right to Buy Common Stock) | 10000 | $0.00 | 171,000.0000 | 191,595,000 | 5.52% | 0.01% |
| Jan. 8, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Director | L | Common Stock | 50 | $99.05 | 672,695.0000 | 191,595,000 | 0.01% | 0.00% |
| Dec. 21, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Director | M | Common Stock | 10000 | $63.10 | 682,645.0000 | 188,963,000 | 1.49% | 0.01% |
| Dec. 21, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Director | S | Common Stock | 10000 | $93.99 | 672,645.0000 | 188,963,000 | 1.46% | 0.01% |
| Dec. 21, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Director | M | Stock Option (Right to Buy Common Stock) | 10000 | $0.00 | 181,000.0000 | 188,963,000 | 5.24% | 0.01% |
| Oct. 4, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Director | L | Common Stock | 10 | $85.57 | 670,275.0000 | 188,963,000 | 0.00% | 0.00% |
| Dec. 1, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Director | A | Common Stock | 2370 | $0.00 | 672,645.0000 | 188,963,000 | 0.35% | 0.00% |
| Nov. 7, 2023 | Immunome Inc. | $IMNM | BIENAIME JEAN JACQUES | Director | A | Stock option (right to buy) | 40696 | $0.00 | 40,696.0000 | 0 | 9999.99% | 0.00% |
| Aug. 8, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Chief Executive Officer | S | Common Stock | 6000 | $88.29 | 670,265.0000 | 188,963,000 | 0.89% | 0.00% |
| Aug. 7, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Chief Executive Officer | S | Common Stock | 4000 | $88.10 | 676,265.0000 | 188,963,000 | 0.59% | 0.00% |
| May 12, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Chief Executive Officer | M | Common Stock | 39130 | $67.81 | 712,876.0000 | 188,963,000 | 5.81% | 0.02% |
| May 12, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Chief Executive Officer | M | Common Stock | 7370 | $67.81 | 720,246.0000 | 188,963,000 | 1.03% | 0.00% |
| May 12, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Chief Executive Officer | F | Common Stock | 6337 | $93.93 | 713,909.0000 | 188,963,000 | 0.88% | 0.00% |
| May 12, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Chief Executive Officer | F | Common Stock | 33644 | $93.93 | 680,265.0000 | 188,963,000 | 4.71% | 0.02% |
| May 12, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Chief Executive Officer | M | Stock Option (Right to Buy Common Stock) | 39130 | $0.00 | 0.0000 | 188,963,000 | 100.00% | 0.02% |
| May 12, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Chief Executive Officer | M | Stock Option (Right to Buy Common Stock) | 7370 | $0.00 | 0.0000 | 188,963,000 | 100.00% | 0.00% |
| May 11, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Chief Executive Officer | M | Common Stock | 30000 | $67.81 | 703,746.0000 | 188,963,000 | 4.45% | 0.02% |
| May 11, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Chief Executive Officer | S | Common Stock | 24439 | $94.55 | 679,307.0000 | 188,963,000 | 3.47% | 0.01% |
| May 11, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Chief Executive Officer | S | Common Stock | 5561 | $95.22 | 673,746.0000 | 188,963,000 | 0.82% | 0.00% |
| May 11, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Chief Executive Officer | M | Stock Option (Right to Buy Common Stock) | 30000 | $0.00 | 39,130.0000 | 188,963,000 | 43.40% | 0.02% |
| May 9, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Chief Executive Officer | M | Stock Option (Right to Buy Common Stock) | 30000 | $0.00 | 99,130.0000 | 188,963,000 | 23.23% | 0.02% |
| May 9, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Chief Executive Officer | M | Stock Option (Right to Buy Common Stock) | 30000 | $0.00 | 69,130.0000 | 188,963,000 | 30.26% | 0.02% |
| April 28, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Chief Executive Officer | A | Common Stock | 317 | $66.88 | 673,746.0000 | 188,963,000 | 0.05% | 0.00% |
| May 10, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Chief Executive Officer | M | Common Stock | 30000 | $67.81 | 703,746.0000 | 188,963,000 | 4.45% | 0.02% |
| May 10, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Chief Executive Officer | S | Common Stock | 21453 | $94.65 | 682,293.0000 | 188,963,000 | 3.05% | 0.01% |
| May 10, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Chief Executive Officer | S | Common Stock | 8547 | $95.34 | 673,746.0000 | 188,963,000 | 1.25% | 0.00% |
| May 9, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Chief Executive Officer | M | Common Stock | 30000 | $67.81 | 703,746.0000 | 188,963,000 | 4.45% | 0.02% |
| May 9, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Chief Executive Officer | S | Common Stock | 13626 | $94.22 | 690,120.0000 | 188,963,000 | 1.94% | 0.01% |
| May 9, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Chief Executive Officer | S | Common Stock | 14964 | $95.49 | 675,156.0000 | 188,963,000 | 2.17% | 0.01% |
| May 9, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Chief Executive Officer | S | Common Stock | 1410 | $95.90 | 673,746.0000 | 188,963,000 | 0.21% | 0.00% |
| April 10, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Chief Executive Officer | S | Common Stock | 10000 | $99.56 | 673,429.0000 | 188,963,000 | 1.46% | 0.01% |
| April 10, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Chief Executive Officer | M | Common Stock | 10000 | $67.81 | 683,429.0000 | 188,963,000 | 1.48% | 0.01% |
| April 10, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Chief Executive Officer | M | Stock Option (Right to Buy Common Stock) | 10000 | $0.00 | 129,130.0000 | 188,963,000 | 7.19% | 0.01% |
| April 6, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Chief Executive Officer | S | Common Stock | 10000 | $96.13 | 673,429.0000 | 188,963,000 | 1.46% | 0.01% |
| April 6, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Chief Executive Officer | M | Stock Option (Right to Buy Common Stock) | 10000 | $0.00 | 139,130.0000 | 188,963,000 | 6.71% | 0.01% |
| April 6, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Chief Executive Officer | M | Common Stock | 10000 | $67.81 | 683,429.0000 | 188,963,000 | 1.48% | 0.01% |
| March 16, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Chief Executive Officer | F | Common Stock | 88623 | $93.41 | 673,429.0000 | 188,963,000 | 11.63% | 0.05% |
| March 15, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Chief Executive Officer | F | Common Stock | 9437 | $87.74 | 762,052.0000 | 188,963,000 | 1.22% | 0.00% |
| March 15, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Chief Executive Officer | A | Common Stock | 36100 | $0.00 | 771,489.0000 | 188,963,000 | 4.91% | 0.02% |
| March 15, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Chief Executive Officer | A | Stock Option (Right to buy Common Stock) | 49430 | $0.00 | 49,430.0000 | 188,963,000 | 9999.99% | 0.03% |
| March 10, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Chief Executive Officer | M | Stock Option (Right to buy Common Stock) | 15000 | $0.00 | 157,130.0000 | 188,963,000 | 8.71% | 0.01% |
| March 10, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Chief Executive Officer | M | Common Stock | 15000 | $67.81 | 750,389.0000 | 188,963,000 | 2.04% | 0.01% |
| March 10, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Chief Executive Officer | S | Common Stock | 15000 | $92.28 | 735,389.0000 | 188,963,000 | 2.00% | 0.01% |
| March 13, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Chief Executive Officer | M | Common Stock | 8000 | $67.81 | 743,389.0000 | 188,963,000 | 1.09% | 0.00% |
| March 13, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Chief Executive Officer | S | Common Stock | 8000 | $90.45 | 735,389.0000 | 188,963,000 | 1.08% | 0.00% |
| March 13, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Chief Executive Officer | M | Stock Option (Right to buy Common Stock) | 8000 | $0.00 | 149,130.0000 | 188,963,000 | 5.09% | 0.00% |
| Feb. 28, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Chief Executive Officer | A | Common Stock | 89700 | $0.00 | 657,557.0000 | 188,963,000 | 15.80% | 0.05% |
| Feb. 28, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Chief Executive Officer | A | Common Stock | 44860 | $0.00 | 702,417.0000 | 188,963,000 | 6.82% | 0.02% |
| Feb. 28, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Chief Executive Officer | A | Common Stock | 32972 | $0.00 | 735,389.0000 | 188,963,000 | 4.69% | 0.02% |
| Feb. 10, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Chief Executive Officer | S | Common Stock | 15000 | $110.11 | 567,757.0000 | 188,963,000 | 2.57% | 0.01% |
| Feb. 13, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Chief Executive Officer | M | Common Stock | 6000 | $67.81 | 573,757.0000 | 188,963,000 | 1.06% | 0.00% |
| Feb. 13, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Chief Executive Officer | S | Common Stock | 6000 | $109.15 | 567,757.0000 | 188,963,000 | 1.05% | 0.00% |
| Feb. 10, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Chief Executive Officer | M | Stock Option (Right to buy Common Stock) | 15000 | $0.00 | 178,130.0000 | 188,963,000 | 7.77% | 0.01% |
| Feb. 10, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Chief Executive Officer | M | Stock Option (Right to buy Common Stock) | 6000 | $0.00 | 172,130.0000 | 188,963,000 | 3.37% | 0.00% |
| Feb. 7, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Chief Executive Officer | G | Common Stock | 100 | $0.00 | 567,757.0000 | 188,963,000 | 0.02% | 0.00% |
| Feb. 7, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Chief Executive Officer | G | Common Stock | 100 | $0.00 | 567,757.0000 | 188,963,000 | 0.02% | 0.00% |
| Feb. 10, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Chief Executive Officer | M | Common Stock | 15000 | $67.81 | 582,757.0000 | 188,963,000 | 2.64% | 0.01% |
| Feb. 7, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Chief Executive Officer | G | Common Stock | 200 | $0.00 | 567,757.0000 | 188,963,000 | 0.04% | 0.00% |
| Dec. 28, 2022 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Chief Executive Officer | G | Common Stock | 100 | $0.00 | 567,857.0000 | 0 | 0.02% | 0.00% |
| Jan. 13, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Chief Executive Officer | M | Stock Option (Right to buy Common Stock) | 10000 | $0.00 | 203,130.0000 | 188,963,000 | 4.69% | 0.01% |
| Jan. 17, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Chief Executive Officer | M | Stock Option (Right to buy Common Stock) | 10000 | $0.00 | 193,130.0000 | 188,963,000 | 4.92% | 0.01% |
| Jan. 17, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Chief Executive Officer | S | Common Stock | 10000 | $111.55 | 567,957.0000 | 188,963,000 | 1.73% | 0.01% |
| Jan. 13, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Chief Executive Officer | S | Common Stock | 10000 | $112.25 | 567,957.0000 | 188,963,000 | 1.73% | 0.01% |
| Jan. 13, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Chief Executive Officer | M | Common Stock | 10000 | $67.81 | 577,957.0000 | 188,963,000 | 1.76% | 0.01% |
| Jan. 17, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | BIENAIME JEAN JACQUES | Chief Executive Officer | M | Common Stock | 10000 | $67.81 | 577,957.0000 | 188,963,000 | 1.76% | 0.01% |